Outcomes after virologic failure of first-line ART in South Africa (Q33985234)

30 July 2017

Outcomes after virologic failure of first-line ART in South Africa (English)

1 reference

30 July 2017

0 references

0 references

Richard A Murphy

1

0 references

Vincent C Marconi

object named as

Vincent C Marconi

11

0 references

Elena Losina

object named as

Elena Losina

5

0 references

Douglas T. Ross

7

object named as

Douglas Ross

1 reference

30 July 2017

10

Daniel R Kuritzkes

1 reference

30 July 2017

Henry Sunpath

2

1 reference

30 July 2017

Zhigang Lu

3

1 reference

30 July 2017

Neville Chelin

4

1 reference

30 July 2017

Michelle Gordon

6

1 reference

30 July 2017

Aba D Ewusi

8

1 reference

30 July 2017

Lynn T Matthews

9

1 reference

30 July 2017

South Africa Resistance Cohort Study Team

12

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 April 2010

1 reference

30 July 2017

1 reference

30 July 2017

24

1 reference

30 July 2017

1007-1012

1 reference

30 July 2017

7

1 reference

Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902159

The reverse transcriptase 67N 70R 215Y genotype is the predominant TAM pathway associated with virologic failure among HIV type 1C-infected adults treated with ZDV/ddI-containing HAART in southern Africa

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902159

Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902159

Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902159

Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902159

The antiretroviral rollout and drug-resistant HIV in Africa: insights from empirical data and theoretical models

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902159

Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902159

Adherence to HAART and its principal determinants in a cohort of Senegalese adults

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902159

Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902159

Adherence is not a barrier to successful antiretroviral therapy in South Africa

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20397305

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1097/QAD.0B013E3283333639

1 reference

30 July 2017

1 reference

30 July 2017

1 reference